Baseline derived neutrophil-to-lymphocyte ratio as a prognostic biomarker for non-colorectal gastrointestinal cancer patients treated with immune checkpoint blockade.

CONCLUSION: Higher dNLR level was correlated with worse outcomes, suggesting that dNLR may help risk-group stratification and assist disease management strategies as a prognostic biomarker for non-colorectal GI patients receiving ICB. PMID: 31953149 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31953149?dopt=Abstract

Source: Clinical Immunology - January 13, 2020 Category: Allergy & Immunology Authors: Li S, Zou J, Liu C, Jiao X, Gong J, Li J, Wang Z, Lu M, Lu Z, Shen L Tags: Clin Immunol Source Type: research